This document has been endorsed by the International Society for Pharmacoepidemiology as policy and has been posted on their website as a preprint version.
Guidelines for good database selection and use in pharmacoepidemiology research†
Version of Record online: 8 NOV 2011
Copyright © 2011 John Wiley & Sons, Ltd.
Pharmacoepidemiology and Drug Safety
Volume 21, Issue 1, pages 1–10, January 2012
How to Cite
Hall, G. C., Sauer, B., Bourke, A., Brown, J. S., Reynolds, M. W. and Casale, R. L. (2012), Guidelines for good database selection and use in pharmacoepidemiology research. Pharmacoepidem. Drug Safe., 21: 1–10. doi: 10.1002/pds.2229
- Issue online: 4 JAN 2012
- Version of Record online: 8 NOV 2011
- Manuscript Accepted: 19 JUL 2011
- Manuscript Revised: 4 JUL 2011
- Manuscript Received: 8 MAR 2011
- 2Registries for Evaluating Patient Outcomes: A User's Guide. April 2007: http://www.effectivehealthcare.ahrq.gov/repFiles/PatOutcomes.pdf., .
- 3Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part I. Value Health 2009; 12(8): 1044–52., , , .
- 6ISPOR. (2010). “International Digest of Databases.” Retrieved June 2010, from http://www.ispor.org/DigestOfIntDB/CountryList.aspx.
- 9Defining and Evaluating Possible Database Models to Implement the FDA Sentinel Initiative. Report to the U.S. Food and Drug Administration, Contract No. HHSF223200831315P; May 2009. From http://www.regulations.gov/search/Regs/home.html#documentDetail?R=090000648098c282, , , .
- 13Guidelines for coding of SAS® programs. In Proceedings of the Twenty-ninth Annual SAS® Users Group International Conference. SAS Institute Inc.: Cary, NC and Montréal, Canada, Paper 258–29 2004..